Podcasts about omada health

Most medical care is backed by varying types of evidence, yet we apply higher standards to digital health tools before they're trusted, adopted, or reimbursed.In this special episode, guest host Lucia Savage is joined by Dr. Vindell Washington of Verily and Dr. Aaron Carroll of AcademyHealth for a candid conversation about the uneven standards we apply to digital versus traditional care. Together, they explore how we define evidence, whose voices shape that definition, and what it takes to build trust in an AI-powered healthcare future.We cover:

All 17 experts have been fired from the Centers for Disease Control and Prevention's independent vaccine panel. A new poll finds that the recent One Big Beautiful Bill Act--and its cuts to Medicaid--is raising concerns among voters. And, digital chronic condition management company Omada Health has had the second splashy digital health IPO in the last month. Those stories and more coming up on today's episode of the Gist Healthcare podcast. Hosted on Acast. See acast.com/privacy for more information.

Let us know what you think about Health Affairs podcasts at communications@healthaffairs.org. If you have 30 minutes to spare, let us know and we'll set up a 30-minute chat for the first 20 listeners that reach out. Coffee will be on us.Health Affairs' Jeff Byers welcomes Christina Farr, advisor, investor, editor-in-chief of Second Opinion Media, to the pod to discuss recent moves by Omada Health and Hinge Health to take the companies public, how the IPOs could impact the digital health market, and what gains her attention when companies make their investment pitches.Health Affairs released their first trend report, which is exclusive for Health Affairs Insiders. The first report focuses on AI in health care and you can get full access to this report by becoming an Insider. Insiders also will receive access to our June 17 event on risk adjustment trends.Related Links:Pre-order Christina Farr's upcoming book, The Storyteller's Advantage: How Powerful Narratives Make Businesses ThriveSign up for Second Opinion Media's newsletters

Subscribe to UnitedHealthcare's Community & State newsletter.Health Affairs' Jeff Byers welcomes Christina Farr, advisor, investor, editor-in-chief of Second Opinion Media, to the pod to discuss recent moves by Omada Health and Hinge Health to take the companies public, how the IPOs could impact the digital health market, and what gains her attention when companies make their investment pitches. Health Affairs released their first trend report, which is exclusive for Health Affairs Insiders. The first report focuses on AI in health care and you can get full access to this report by becoming an Insider. Insiders also will receive access to our June 17 event on risk adjustment trends.Related Links:Pre-order Christina Farr's upcoming book, The Storyteller's Advantage: How Powerful Narratives Make Businesses ThriveSign up for Second Opinion Media's newsletters Subscribe to UnitedHealthcare's Community & State newsletter.

Holistic support, including lifestyle changes, is essential for weight management and diabetes, as GLP-1 medications are only one part of the solution. In this episode, Dr. Carolyn Jasik, the Chief Medical Officer of Omada Health, discusses their approach to GLP-1s, emphasizing the importance of wraparound support, including mental health and physical therapy, as well as addressing concerns like muscle loss and the sustainability of weight loss. She highlights that the goal for many people is not to be on these medications forever and that an important element to consider is the rebound physiology that could drive people to regain weight after stopping treatment. Dr. Jasik also shares Omada's perspective on AI, explaining how it assists providers with clinical decision support based on their vast member history but doesn't replace the human connection needed for empathetic care.  Tune in and learn how Omada is leveraging AI to create a more personalized and effective healthcare experience that also focuses on long-term sustainability! Resources: Connect with and follow Dr. Carolyn Jasik on LinkedIn. Discover more about Omada Health on LinkedIn and their website.

Navigating AI disruption is like steering a ship—startups move like speedboats, while enterprises must turn the equivalent of a cruise liner. In this episode, host Hannah Clark speaks with Randhir Vieira, Chief Product Officer at Omada Health, about how established companies can adapt to AI-driven change despite their size and complexity.With over a decade in operation, Omada Health faces different challenges than AI-native startups. Randhir shares strategies for integrating AI into both product development and company culture, offering insights on how enterprise leaders can stay agile and competitive in this fast-changing landscape.Resources from this episode:Subscribe to The Product Manager newsletterConnect with Randhir on LinkedInCheck out Omada Health

In this episode of the Pharmacy View Podcast's Rx to Riches stream, international host Michael Alexander, a Pharmacist, entrepreneur, digital health enthusiast, Co-Founder of Audirie, and the Regional Vice-President of Health Plans at Omada Health, speaks with Surge Singh, Co-Founder of Locumate and Locumate.ai. Surge shares how their platform is transforming the way Pharmacists connect with locum opportunities, addressing inefficiencies that have long plagued the industry. What started as a personal frustration—when Surge's wife received an unexpectedly high invoice for a locum Pharmacist—led to the creation of a holistic talent orchestration platform. By leveraging high-tech solutions and combining technology with human interaction, Locumate has grown from a simple marketplace into an end-to-end staffing solution, making it easier for Pharmacies to find the right professionals quickly and efficiently. Over the past 2 years, Locumate has evolved significantly, expanding from a transactional marketplace into a comprehensive workforce management system. Initially, Pharmacies sought locums through external agencies, but Surge and their team recognised a broader issue: many Pharmacies first search within their internal networks before turning to external sources. To address this, Locumate developed a seamless solution that integrates internal talent pools, personal networks, agencies, and marketplaces, allowing Pharmacies to access the best professionals at the click of a button. This shift positions Locumate as a true orchestration engine for healthcare staffing, ensuring that the right professionals are matched with the right opportunities. Finding a suitable locum has often been compared to a blind date—uncertain and sometimes mismatched. Locumate is solving this by incorporating shift feedback data to identify workforce gaps and partnering with training providers like Audirie and the Pharmaceutical Society of Australia. By integrating AI-driven talent matching, the platform now ensures that the best-suited locum is placed in each Pharmacy, rather than just filling shifts. Demand from industry professionals has also led to Locumate's expansion into other healthcare sectors, including physiotherapy and podiatry, further cementing its role as a scalable, multi-sector solution. Surge shares the journey of expanding into the U.S. market, a process that began with a chance conversation at an accelerator program and led to a pivotal meeting at the NCPA conference in Kansas City. Despite initial scepticism, a simple chat over a pumpkin spice latte with the CEO of the California Pharmacy Association resulted in a strategic partnership with the American Pharmacists Association, opening doors for Locumate in the U.S. However, breaking into the market required board approvals, legal navigation, and compliance with strict regulations, particularly in California. Looking ahead, Locumate is positioning itself as Australia's first AI-enabled job board for Pharmacy, with plans to expand into the U.S. and other allied health sectors. The platform is broadening its scope to include Pharmacy technicians, retail staff, and students, while also focusing on workforce skill development through collaborations with organisations like the American Pharmacy Association. In the next five years, AI-driven recommendations will help Pharmacy professionals identify ideal career paths based on their skills and personalities, removing guesswork from job matching. Surge highlights the need for a mindset shift in the Australian Pharmacy industry, urging professionals to embrace technology-driven workforce solutions rather than resisting change. Ultimately, Locumate aims to revolutionise Pharmacy workforce management, ensuring that both professionals and employers benefit from a more structured, data-driven approach.

Welcome to another episode of Supra Insider. This time, Marc and Ben sat down with Randhir Vieira, Chief Product Officer at Omada Health and a Supra facilitator. Randhir has led product teams at companies like Headspace and brings a deep passion for leadership, communication, and the often-overlooked skill of listening.In this episode, we explore why listening is the foundation of strong leadership, how to give feedback that actually lands, and why the best product leaders focus on building psychological safety in their teams. Randhir also shares practical frameworks for improving team collaboration, handling difficult conversations, and fostering a culture of trust.If you're a product leader looking to sharpen your leadership skills, a founder building a team, or someone navigating tricky workplace dynamics, this conversation is packed with actionable takeaways.All episodes of the podcast are also available on Spotify, Apple and YouTube.New to the pod? Subscribe below to get the next episode in your inbox

About Dr. Carolyn Jasik:Carolyn is a board-certified physician with a background in health technology startups, multidisciplinary care, education, and research. As Chief Medical Officer at Omada, she uses her diverse expertise to improve user experience and introduce integrated healthcare solutions. Before joining Omada, Carolyn spent 14 years at the University of California as an Associate Professor of Pediatrics and Clinical Instructor at San Francisco General Hospital. She also served as Vice President of Medical Outcomes at Mango Health, a digital health startup. Carolyn earned a Bachelor's in Public Policy from Princeton University, a Medical Degree from the University of Chicago's Pritzker School of Medicine, and completed her research training at the University of California, San Francisco. She is board-certified in clinical informatics, adolescent medicine, and pediatrics. At Omada, Carolyn supports clinical and research teams, contributing to the development of innovative healthcare solutions.Things You'll Learn:GLP-1 medications require comprehensive wraparound support, including lifestyle changes, mental health, and physical therapy, for effective and sustainable outcomes. The speed of weight loss, rather than the GLP-1 itself, is often the primary driver of muscle mass reduction.Many individuals on GLP-1s aim to eventually discontinue the medication, making long-term lifestyle planning a crucial part of the treatment.Stopping GLP-1s abruptly can trigger rebound weight gain due to the body's natural metabolic response.AI's role in healthcare should be focused on enhancing human care delivery, not replacing the crucial empathetic connection.The future of healthcare will include advanced primary care that addresses the gaps between traditional doctor visits.Resources:Connect with and follow Dr. Carolyn Jasik on LinkedIn.Discover more about Omada Health on LinkedIn and their website.

In this episode, we speak with Sean Duffy, the Co-Founder and CEO of Omada Health, a virtual-first healthcare provider that nurtures lifelong health, one day at a time. Since 2011, Sean and his team's mission has been to inspire and enable people everywhere to live free of chronic disease. They do this by building digital health programs that are evidence-based, performance-priced, and designed to delight their users. Omada is backed by Andreessen Horowitz, Norwest Venture Partners, Fidelity, Wellington Management, and other notable investors. I am your host RJ Lumba.  We hope you enjoy the show.  If you like the episode click to follow.

In this episode of CISO Tradecraft, host G. Mark Hardy sits down with Bill Dougherty, CISO of Omada Health, to discuss a groundbreaking threat model called 'Includes No Dirt'. This comprehensive model integrates security, privacy, and compliance considerations, aiming to streamline and enhance threat modeling processes. The conversation covers the origin and principles of the model, its applicability across different sectors, and the essential aspects of threat modeling. Listeners are also treated to insights on handling third-party risks and adapting to emerging AI challenges. The episode provides practical advice for cybersecurity leaders looking to effectively manage and mitigate risks while reducing redundancy.   Big Thanks to our Sponsors: ZeroPath - https://zeropath.com/ CruiseCon - Use code CISOTRADECRAFT10 at https://cruisecon.com/ for 10% off registration!   The No DIRT Threat Model can be found here: http://www.includesnodirt.com/nodirt.pdf   Transcripts: https://docs.google.com/document/d/1vWq4Zx7pzM_B65W933m8_TE0fLKaUw3X   Chapters 03:27 The Genesis of Includes No Dirt 05:05 Combining Security, Privacy, and Compliance 07:24 Implementing the No Dirt Model 11:42 Scoring and Evaluating Risks 17:41 Third-Party Risk Management 25:49 Evaluating SaaS Requests Based on Risk 27:55 Adapting Threat Models for AI 31:24 Principles of Minimum Necessary Data 33:42 General Applicability of Security Principles 35:12 Includes No Dirt: A Comprehensive Threat Model 40:15 Final Thoughts and Recommendations

Vidya Dinamani and Heather Samarin dive into the world of customer-driven innovation with Omada Health's CPO, Randhir Vieira. Randhir shares how scrappy research methods, empathy-led design, and outcome-focused metrics shape better products. He also discusses his insights on aligning teams, navigating rapid prototyping, and balancing speed with meaningful results. 

In this episode of the Pharmacy View Podcast's Rx to Riches stream, international host Michael Alexander, a Pharmacist, entrepreneur, digital health enthusiast, Co-Founder of Audirie, and the Regional Vice-President of Health Plans at Omada Health, speaks with Angela Stathopoulos, Group Manager of Education and Development at Chemist Warehouse. With nearly 30 years of experience across community, regulatory, and hospital Pharmacy sectors, Angela discusses her dedication to fostering the next generation of Pharmacy professionals. She elaborates on Chemist Warehouse's dynamic approach to training, highlighting initiatives aimed at advancing Pharmacy practice, developing new services, and supporting early-career Pharmacists. Angela's journey reflects a passion for embracing opportunities, which she encourages in those looking to grow within the field. Angela dives into the extensive training programs offered by Chemist Warehouse, ranging from an internally developed internship program to advanced CPD courses. Key initiatives like "Leading for the Future" and "Step Up" were designed to meet the evolving demands of the Pharmacy industry, and Angela explains that these programs were developed in consultation with stakeholders, providing both leadership training and support for early-career Pharmacists. Her approach emphasises Chemist Warehouse's commitment to equipping Pharmacists with essential skills to navigate the ever-changing Pharmacy landscape while ensuring consistent, high-quality training across all locations. To achieve this consistency, Angela describes a hybrid model of in-person and online training, made possible through platforms like Zoom and AI-driven tools for Pharmacy assistant training. The integration of AI, she explains, is pivotal for maintaining scalable and standardised training, especially across Australia's remote areas. However, Angela stresses that AI tools are only as effective as the team managing them, ensuring that quality standards are met. This combination of technology and human oversight allows Chemist Warehouse to meet the educational needs of Pharmacists in varied geographic regions while maintaining flexibility and adaptability. Internationally, Angela shares the challenges and successes of adapting Chemist Warehouse's Australian training models for different regions, such as New Zealand, Ireland, and the UAE. Each region brings unique regulatory and cultural needs, requiring collaboration with local experts to ensure training aligns with local standards. Angela emphasises the importance of collecting feedback from both trainees and regional authorities, which informs improvements and adjustments to training programs. This feedback loop is essential for refining programs in a way that balances the needs of learners and the organisation, ensuring a strong return on investment. The conversation then shifts to the evolving skill requirements for Pharmacists, which have expanded from purely clinical skills to include critical soft skills like empathy, communication, and problem-solving. Angela explains that while technical expertise remains foundational, handling complex patient interactions and regulatory issues requires a broader skill set. Closing on a light-hearted note, Michael humorously offers Angela "magic powers" to enhance Chemist Warehouse's training program, to which Angela replies that she would clone her dedicated team to better address training demands. They discuss upcoming programs, such as the "Step Up" initiative for student Pharmacists and a Managing Partner pathway aimed at guiding Pharmacists from entry-level roles to ownership opportunities within the company. Angela's insights reveal Chemist Warehouse's focus on career development and innovation, underscoring their commitment to expanding Pharmacists' clinical responsibilities and supporting a holistic approach to patient care.

About Gabe Castaneda:Gabe Castaneda is the Chief Revenue Officer at FlyteHealth, bringing over 25 years of experience in sales, marketing, and customer success in both business-to-business and direct-to-consumer markets. He has held significant roles at Omada Health, Blue Cross and Blue Shield, and UnitedHealth Group. Gabe holds a bachelor's degree in marketing from the University of Minnesota, a law degree from the Mitchell Hamline School of Law, and an MBA from the Thunderbird School of Global Management. His expertise lies in developing strategic sales and marketing organizations, reducing costs, improving health outcomes, and increasing member engagement.Things You'll Learn:Innovative obesity management combines lifestyle strategies with clinical medication management using a patented algorithm for personalized care.Significant weight loss results, averaging 15.8% with non-GLP-1s, reduce costs and minimize side effects.Avoiding compound prescriptions is a critical focus in effective obesity management.Efforts center on building state-level partnerships with healthcare systems and expanding collaborations with payers, consultants, and employer groups.Resources:Connect with and follow Gabe Castaneda on LinkedIn.Follow FlyteHealth on LinkedIn and visit their website. 

According to Business Insider, Omada Health has quietly filed its S-1 to prepare for an IPO. Here's how Sean Duffy (CEO & Co-founder) built it. 0:00 Intro 0:17 Signing first customer 1:51 How to have good ideas in healthcare 4:00 Why metabolic health is a hard area to innovate in 5:18 What the MVP product looked like 11:16 Sean's secret tactics 14:55 Operational innovation as a differentiator 20:19 The Omada playbook — is it repeatable? 25:31 What boss moves have you made Sean? 29:37 The difference between good and great 32:29 Sean's best tip on selling in enterprise healthcare 33:35 Sean's advice to himself Links Omada Health: https://www.omadahealth.com Dr Mustafa Sultan: ⁠⁠https://www.musty.io⁠

In this captivating second part of the Pharmacy View Podcast's Rx to Riches stream, international host Michael Alexander, a Pharmacist, entrepreneur, digital health enthusiast, Co-Founder of Audirie, and the Regional Vice-President of Health Plans at Omada Health, continues his insightful conversation with Erin Fawcett, the Executive Director of Education and Professional Development at NAPSA, and Sebastian Harper, the National President of NAPSA. Together, they explore how NAPSA is driving innovation in Pharmacy education and empowering students to excel in a rapidly evolving healthcare landscape. From AI-driven tools to fostering interprofessional collaboration, this episode sheds light on the transformative initiatives shaping the future of Pharmacy practice. The discussion delves into the rising prominence of Pharmacist-led prescribing and other advanced roles within the healthcare system. Erin highlights NAPSA's use of cutting-edge technologies, such as AI-powered counselling simulations, to prepare students for the complexities of modern patient care. Sebastian adds that NAPSA's initiatives encourage students to expand their skills beyond traditional degrees, focusing on enhancing patient care through continuous learning and innovation. Together, they underscore the importance of education and teamwork in addressing challenges like disease management and medication accessibility. The episode also explores the integration of AI into Pharmacy education and its impact on team training. Michael introduces Audirie's AI-driven simulations for NAPSA members, enabling students to practise patient interactions with precision and confidence. Erin and Sebastian discuss how AI complements traditional training, helping all Pharmacy team members—from Pharmacists to assistants—perform at the top of their scope. This holistic approach aims to bridge skill gaps and elevate the overall standard of patient care, highlighting the critical balance between technology and human expertise in healthcare. Addressing the barriers in Pharmacy education, the conversation turns to placement opportunities and financial challenges. Erin advocates for reforms to ensure students have access to earlier and paid placements, improving experiential learning. Sebastian emphasises the value of rural placements for interprofessional collaboration and community impact, while Michael calls on universities and governments to ease the financial burdens that deter students from pursuing careers in underserved areas. These measures are seen as vital to building a robust and sustainable Pharmacy workforce. The episode concludes with excitement about the upcoming NAPSA Congress, the pinnacle event for Pharmacy students in Australia. Hosted at the University of Queensland, this week-long conference offers educational sessions, workshops, a trade expo, and vibrant social events. Sebastian shares their hopes for record-breaking attendance, while Erin highlights the benefits of NAPSA membership, including networking, scholarships, and mentoring opportunities. Together, they celebrate the Congress's enduring legacy and its role in shaping the future of Pharmacy in Australia and New Zealand.

Raj Gokal is the co-founder of Solana and president of Solana Labs. He also serves on the board of the Solana Foundation. He was previously focused on startups in behavioral health. He was Director of Product at Omada Health; EIR at Rock Health; Co-Founder of Sano, building consumer glucose sensors; and an investor at General Catalyst Partners. He started his career in hedge funds at companies like Meridian Capital Partners. Raj studied Finance at the Wharton School of UPenn.

In this engaging episode of the Pharmacy View Podcast's Rx to Riches stream, international host Michael Alexander, a Pharmacist, entrepreneur, digital health enthusiast, Co-Founder of Audirie, and the Regional Vice-President of Health Plans at Omada Health, hosts Erin Fawcett, the Executive Director of Education and Professional Development at NAPSA, and Sebastian Harper, the National President of NAPSA. Together, they delve into the transformative roles of education, leadership, and advocacy in shaping the future of the Pharmacy profession. With personal insights, professional experiences, and a shared passion for advancing the Pharmacy industry, this episode offers an inspiring and thought-provoking conversation. Erin and Sebastian discuss the significant impact of NAPSA (National Australian Pharmacy Students' Association) on Pharmacy students' professional growth. Erin highlights how NAPSA acts as the peak advocacy body for students, offering unparalleled networking opportunities that build professional relationships and enhance knowledge for future success. Sebastian underscores the importance of NAPSA's national advocacy efforts, ensuring student concerns are heard by government bodies and stakeholders. Michael reflects on his own career, encouraging students to prioritise networking to unlock new opportunities and further their professional development. A key focus of the episode is NAPSA's efforts to combat "placement poverty," a pressing issue for students facing financial burdens during mandatory placements. Erin and Sebastian outline their campaign for government support similar to that provided to nursing students, aiming to make university more accessible amidst the rising cost-of-living pressures. Their advocacy reflects a broader mission to support Pharmacy students by improving accessibility and fostering an inclusive educational environment that enables future professionals to thrive. The discussion also explores the challenges and rewards of balancing leadership responsibilities at NAPSA with full-time studies and work commitments. Erin shares how teamwork and a shared vision for advancing the Pharmacy profession fuel their dedication to student advocacy, while Sebastian highlights the role of collaboration among NAPSA committees in managing the workload effectively. Both emphasise the lasting impact of their initiatives on the Pharmacy community, illustrating how passion and teamwork drive meaningful progress. Erin and Sebastian conclude with an inspiring vision for the future of Pharmacy, imagining a shift towards greater accessibility and a service-based model. They envision Pharmacies becoming integral hubs in Australia's healthcare system, leveraging Pharmacists' expertise to ease pressures on the system and enhance patient care. This is only the beginning of their insightful discussion, with Part Two of this engaging conversation set to be released next week. Stay tuned!

In this episode with Dr. Cameron Sepah, you'll get to dive into critical topics like the alarming drop in testosterone and sperm counts, the dangers of endocrine-disrupting chemicals, and why testosterone replacement therapy (TRT) could harm fertility. You'll explore the difference between primary and secondary hypogonadism, alternative therapies like Clomid or enclomiphene that boost natural testosterone production, and the challenges of maintaining fertility during TRT. You'll also hear about the risks of high estrogen levels, the impact of testosterone on libido, the importance of personalized dosing, and cutting-edge innovations like at-home devices that measure key hormones with clinical accuracy. Dr. Cameron Sepah is the CEO of Maximus, an online medical clinic specializing in health and hormone optimization, backed by top venture capitalists including Founders Fund, 8VC, and angel investors such as Dave Asprey of Bulletproof, Ryan Holiday of the Daily Stoic, and the executives behind The Honest Company, Coinbase, Tinder, and Shopify. Cameron is a serial health tech entrepreneur, as a founding team member of Omada Health, a billion-dollar startup that pioneered the field of digital therapeutics. He is a licensed clinical psychologist by training, specializing in behavioral medicine, and a clinical professor of psychiatry, where he trains doctors in evidence-based health care. Tune in to get all the insights you need to make informed decisions about optimizing your testosterone, fertility, and overall health! Full Show notes: https://bengreenfieldlife.com/maximuspodcast SiPhox: Visit siphoxhealth.com/ben with code BEN to get 20% off your health kit! Pendulum: Get 20% off your first month of any Pendulum probiotic with code GREENFIELD at PendulumLife.com/Greenfield. BEAM Minerals: Up your mineral game. Go to beamminerals.com and use code BEN at checkout for 20% off your order. Organifi: Go to Organifi.com/Ben for 20% off your order. ProLon: Right now, you can save 15% on your 5-day nutrition program when you go to ProLonLife.com/GREENFIELD.See omnystudio.com/listener for privacy information.

In today's episode, I sit down with Sachin Jain, an old friend and very successful CEO of a healthcare company. We discuss how he integrated his interests in social justice and policy with his family's encouragement to pursue medicine, his ideas on mentorship, and the arc of his career.BioSachin H. Jain, MD, MBA is CEO of SCAN Group and SCAN Health Plan, one of the nation's largest not-for-profit Medicare Advantage plans, which serves more than 300,000 members across California, Nevada, Arizona, Texas and New Mexico. Previously, Dr. Jain was President and CEO of CareMore and Aspire Health, which served 200,000 Medicare and Medicaid patients in 32 states. He also served as Chief Medical Information & Innovation Officer at Merck & Co., was Senior Advisor to the Administrator of the Centers for Medicare & Medicaid Services (CMS) and was the first Deputy Director for policy and programs at the Center for Medicare and Medicaid Innovation (CMMI).Dr. Jain graduated from Harvard College and earned his MD from Harvard Medical School and MBA from Harvard Business School. He is Adjunct Professor at the Stanford University School of Medicine and is a member of the boards of America's Health Insurance Plans (AHIP), Omada Health, Advantage Healthcare Services, and The Paul & Daisy Soros Fellowships for New Americans. Follow Sachin on LinkedIn.Access free resources and learn more about Sheila and her team at Signet Education at signeteducation.com or on LinkedIn at https://www.linkedin.com/in/sheilaakbar/.

Until Designer Fund was founded by Enrique Allen and Ben Blumenrose, venture capital investments rarely considered design strategy when investing. Companies like Stripe, Notion, Gusto, and Omada Health—all in Designer Fund portfolio companies—see design as a competitive advantage and a tool for acquiring and retaining customers. Enrique Allen told us all about the tremendous value design is creating in these and many other companies. We spoke with Enrique about how they chose design as an investment lens, the changing role of design from when they started until now, why venture capital might not always be the best way to fund a startup business, and how they think about finding good partners and co-founders. By the way, if you're starting a design-centric company and seeking investment, Designer Fund is investing up to $1 million for pre-seed and Series A startups. To learn more and apply for funding, visit designerfund.com/partnership. Apply by October 4th. Bio Enrique Allen is the co-founder and managing partner at Design Fund. Previously, Enrique was a designer at venture capital firms, including 500 Startups, Facebook's fbFund, and Venrock, where he helped invest in companies like Lyft (NASDAQ: LYFT), Wildfire (acquired by Google) and Behance (acquired by Adobe). He's a Stanford University alum, former Division 1 soccer player and senior lecturer at the Stanford d.school. *** Stay tuned after the interview for a special look at Wix Studio, the intuitive way for agencies and enterprises to design exceptional sites, with full-stack business solutions, multi-site management and built-in AI. We chat with Kyle Prinsloo, founder of ClientManager.io, about why he loves Wix Studio for its efficient tools like the Figma to Wix Studio plugin, and robust email marketing features, which have greatly improved his workflow and client engagement.  To learn more about Wix Studio, visit dbtr.co/wixstudio. *** Premium Episodes on Design Better This ad-supported episode is available to everyone. If you'd like to hear it ad-free, upgrade to our premium subscription, where you'll get an additional 2 ad-free episodes per month (4 total). Premium subscribers also get access to our monthly AMAs with former guests, ad-free episodes, early and discounted access to workshops, and our new enhanced newsletter The Brief that compiles salient insights, quotes, readings, and creative processes uncovered in the show.   Upgrade to paid *** Visiting the links below is one of the best ways to support our show: Incogni: Every year, both the number and scope of data breaches worldwide are rising. According to the 2022 Annual Data Breach Report by the Identity Theft Resource Center, the number of victims has gone up nearly 41.5% from 2021. Incogni reaches out to data brokers on your behalf, requests your personal data removal, and deals with any objections from their side. Use promo code DESIGNBETTER at https://incogni.com/designbetter to get 60% off an annual plan. Learn more about your ad choices. Visit megaphone.fm/adchoices

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. Amazon has partnered with Talkspace to expand its digital health benefits program, which also includes Omada Health. Community Health Systems (CHS) subsidiary is acquiring 10 urgent care centers, following in the footsteps of other for-profit health systems. Steward Health Care auctioned off Glenwood Regional Medical Center for $500,000, but there are concerns about the continued involvement of hospital landlord Medical Properties Trust in operations. The text also includes sponsored content on safeguarding healthcare against ransomware and cybercrime, as well as information on trends in telehealth and strategies for improving provider data accuracy for payers. Healthcare Dive provides news and insights for healthcare leaders and is a publication operated by Industry Dive.Roivant's subsidiary, Dermavant, is being acquired by Organon, giving Organon access to a psoriasis and eczema cream called Vtama. This acquisition will provide Roivant with additional cash to fund its research and development plans. Meanwhile, biotech M&A activity has plateaued, with private company acquisitions continuing while public company acquisitions have slowed down. One biotech, Ratio Therapeutics, backed by Bristol Myers Squibb, is optimistic about the boom in radiopharma and the pharmaceutical industry's shift towards targeted radiation drugs. In other news, Novartis' Kisqali has received expanded FDA approval which could double its market for breast cancer treatment. Additionally, Express Scripts is suing the FTC over a report critical of pharmacy benefit manager business practices. The industry is also exploring new ways to deliver genetic therapies and improve clinical trial execution through systems thinking. Overall, the biopharma industry is experiencing exciting times with various developments and advancements in drug development and healthcare technology.Zimmer has decided to pull its hip implant off the market due to fracture risk, with plans to phase out its use by December. Merit Medical has acquired Cook's lead management business for $210 million, adding devices used in heart rhythm device procedures to its portfolio. Synchron has connected brain-computer interface technology to Amazon Alexa, allowing patients to control various functions without using their hands or voice. Senseonics has received FDA clearance for a one-year continuous glucose monitoring system, and Boston Scientific has closed its acquisition of Silk Road Medical. The wearables market is expected to grow by 13% annually between 2024 and 2030, highlighting the importance of adhesives in wearable device development. AI is increasingly influencing the value chain of medical device companies, and manufacturers are exploring ways to utilize AI throughout the product lifecycle. These developments reflect the ongoing innovation and evolution within the medtech industry.Roivant has sold Dermavant to Organon in a deal worth up to $1.2 billion, allowing Roivant to focus on their autoimmune-focused Immunovant and upcoming trials. Summit Therapeutics' bispecific for non-small cell lung cancer has shown promise against Keytruda but still needs more data. Other news includes the FDA approving Keytruda for pleural mesothelioma, Bernie Sanders claiming generics companies can offer a cheaper alternative to Ozempic, Novartis expanding Kisqali's use in breast cancer, and HRSA threatening sanctions against J&J. In the world of enzyme development, SignalChem Biotech offers tailored services. Additionally, new gene therapies for sickle cell disease are reaching patients, and the race for an obesity pill is heating up among companies like Novo, Roche, and Terns.The FDA is facing challenges with conducting overseas drug manufacturing inspections, with 42% of registered plants overdue for inspections. Indian drugmaker Zydus Lifesciences received a warnin

It's August, and for many families, that means preparing for a return to school. This can be a challenge for kids and parents. Changing routines, decreasing free time, and, for many of our members, new locations can make for bumpy August and September. Our guests today, working from Brightline Health, will provide some strategies for families to ease the return to school for everyone.  Learn more about Brightline Health and sign up for it at www.hellowbrightline.com/fsbp. (Brightline is considered an in-network provider with FSBP. Services are available to FSBP members in the U.S. only. Calendar year deductible and coinsurance apply.)Dr. Kendra Read is a Licensed Clinical Psychologist and Vice President of Therapy at Brightline. She received her Ph.D. in clinical psychology from Temple University in Philadelphia, PA. She completed her internship in pediatric psychology at Nemours Hospital for Children and her postdoctoral fellowship at the Stanford University School of Medicine in the Psychiatry and Behavioral Sciences Department.  Previously, she served as the Director of the Mood & Anxiety Program and Director of Anxiety Programs at Seattle Children's Hospital, as well as the Director of Psychotherapy Training at the University of Washington School of Medicine Child Psychiatry Fellowship. Dr. Read specializes in the treatment of youth with anxiety disorders and OCD from a cognitive behavioral therapy perspective. She is highly invested in increasing access to evidence-based behavioral health interventions for youth and their families.Irene Biscante is a National Board Certified Health and Wellness Coach (NBC-HWC) and the Vice President of Coaching at Brightline. She holds a bachelor's degree in Public Health with an emphasis in Health Education and Promotion from Brigham Young University - Idaho and is currently pursuing a graduate degree in Marriage and Family Therapy with a specialization in Child and Adolescent Therapy at Northcentral University. With over seven years of experience in health and behavior change startups such as Noom, Omada Health, and Sanvello Health, Irene has specialized in scaling evidence-based and personalized behavioral coaching through 1:1 video sessions, secured chat, and group/peer sessions. Irene was part of the early team at Brightline where she established the Behavioral Health Coaching function, built the coaching team, co-created coaching programs using evidence-based tools and practices, and developed quality oversight programs to ensure safe and high quality care services at Brightline. With behavioral coaching as an emerging field and a brand new service offering for youth, she successfully transitioned this offering from a direct-to-consumer, out-of-pocket service to a service covered by health plans and employers due to strong care outcomes across all ages. Prior to joining Brightline, Irene served as a coach manager at Noom Inc., where she managed teams, led hiring and onboarding processes, and was a founding internal faculty member in the company's accredited national board certification program for health coaches. She has coached thousands of individuals both in-person and across digital platforms on a national and international scale. Irene is passionate about expanding access to mental health services independent of income or social status, developing coaches, behavior specialists, and health educators to focus on youth mental health using evidence-based and culturally competent care practices, and reshaping the narrative around youth and family mental health through proactive prevention, early intervention strategies, and behavior change initiatives.

Brooke Boyarsky Pratt, founder and CEO of knownwell, joins Vineeta Agarwala, general partner at a16z Bio + Health.Together, they talk about the value of obesity medicine practitioners, patient-centric medical homes, and how Brooke believes the metabolic health space will evolve over time.This is the second episode in Raising Health's series on the science and supply of GLP-1s. Listen to last week's episode to hear from Carolyn Jasik, Chief Medical Officer at Omada Health, on GLP-1s from a clinical perspective. Listen to more from Raising Health's series on GLP-1s:The science of satiety: https://raisinghealth.simplecast.com/episodes/the-science-and-supply-of-glp-1s-with-carolyn-jasikHow payors, providers and pricing: https://raisinghealth.simplecast.com/episodes/the-science-and-supply-of-glp-1s-with-chronis-manolis Stay Updated: Let us know what you think: https://ratethispodcast.com/a16zFind a16z on Twitter: https://twitter.com/a16zFind a16z on LinkedIn: https://www.linkedin.com/company/a16zSubscribe on your favorite podcast app: https://a16z.simplecast.com/Follow our host: https://twitter.com/stephsmithioPlease note that the content here is for informational purposes only; should NOT be taken as legal, business, tax, or investment advice or be used to evaluate any investment or security; and is not directed at any investors or potential investors in any a16z fund. a16z and its affiliates may maintain investments in the companies discussed. For more details please see a16z.com/disclosures.

Chronis Manolis, SVP and Chief Pharmacy Officer of UPMC Health Plan, joins Julie Yoo, general partner, Daisy Wolf, investment partner, and Will Shrank, venture partner, of a16z Bio + Health.Together, they discuss how payors and providers are thinking about anti-obesity medications, as well as pricing and prior authorization considerations. This is the third episode in our series on the science and supply of GLP-1s. Listen to last week's episode to hear from Brooke Boyarsky Pratt, founder and CEO of knownwell, about the importance of patient-centric medical homes. The week before, we spoke with Carolyn Jasik, Chief Medical Officer at Omada Health, on GLP-1s from a clinical perspective. 

Brooke Boyarsky Pratt, founder and CEO of knownwell, joins Vineeta Agarwala, general partner at a16z Bio + Health.Together, they talk about the value of obesity medicine practitioners, patient-centric medical homes, and how Brooke believes the metabolic health space will evolve over time.This is the second episode in our series on the science and supply of GLP-1s. Listen to last week's episode to hear from Carolyn Jasik, Chief Medical Officer at Omada Health, on GLP-1s from a clinical perspective.

Carolyn Jasik, MD, Chief Medical Officer of Omada Health, joins Vijay Pande, founding partner of a16z Bio + Health.As Ozempic, Wegovy, Mounjaro, and Zepbound capture the healthcare spotlight, we've developed a series of episodes that go beyond the headlines and take you into conversations with the specialists. Our first guest is Carolyn Jasik, Chief Medical Officer at Omada Health. She gives us an overview of the science of satiety, the perspective from obesity-focused physicians, and the sometimes surprising lifestyle implications for patients on these medicines.This series provides insight into what anti-obesity medicines are, where they're going, and the challenges that have to be overcome along the way.

Explore the world of digital healthcare security and the Island enterprise browser with Bill Dougherty, CISO of Omada Health, on episode 839 of CXOTalk. Learn how Omada leverages technology to manage sensitive health data securely and efficiently, all through a virtual-first approach. Bill shares insights on the unique challenges of securing digital health information and the innovative solutions that help protect patient data. Don't miss this in-depth discussion on the intersection of healthcare, security, and technology!#DigitalHealthcare #Cybersecurity #CISO #HealthTech #VirtualHealth #cxotalkRead the transcript with episode highlights and key takeaways:https://www.cxotalk.com/episode/ciso-insights-why-use-an-enterprise-browserSubscribe: newsletter.cxotalk.com

As a medical school-bound undergrad, Sean Duffy, co-founder and CEO of Omada Health, didn't initially consider entrepreneurship as a career path. Today, Sean leads a virtual-first care provider for chronic conditions like diabetes, hypertension, and musculoskeletal disorders. Sean traces his journey from a "techie" upbringing to stints at Google and medical school, and how his early fascination with the potential of digital health ultimately led him to build Omada.Sean and Steve dive into:-The genesis of Omada's "digital DPP" (diabetes prevention program) model-How digital health has matured over the last decade-Omada's approach to driving successful GLP-1 prescription outcomes-The Peterson report questioning the efficacy of diabetes tech-Sean's advice for aspiring entrepreneursSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Welcome back to the Pear Healthcare Playbook! Every week, we'll be getting to know trailblazing healthcare leaders and dive into building a digital health business from 0 to 1. Today, we're so excited to get to know Wei-Li Shao, President of Omada, a virtual care program that blends human experiences technology and behavior science to help people with chronic conditions achieve their healthy goals. With over 25 years of global healthcare experience, Wei-Li has worked in digital care, biopharmaceuticals, imaging, and diagnostics spanning many therapeutic areas. Before joining Omada, Wei-Li held prominent executive roles at Eli Lilly and Company in the USA, China, Taiwan, and New Zealand. His educational background includes dual degrees in biochemistry and molecular biology from the University of Wisconsin Madison, complemented by an MBA in marketing from the Kellogg School of Business. In this episode, we discuss Omada Health's core operations, discuss the optimal timing for startups to bring in C-suite executives, explore Omada's journey to serving 1 million members, examine its pioneering work in the GLP-1 (Glucagon-Like Peptide-1) space, and uncover how Omada leverages AI to enhance its services.

EXCLUSIVE: Omada Health's Wei-Li Shao on Amazon Partnership. Wei-Li Shao, President of Omada Health, joins us to discuss Omada's big splash: being named Amazon's first partner for their new Health Condition programs for managing chronic conditions. Wei-Li shares how this partnership is keeping the human element of healthcare front and center, and how designing experiences outside of the doctor's office is leading to real behavior change at scale.  All that, plus the Flava of the Week about Best Buy Health's year in review. Which of their highlights slipped under the radar in 2023, and what are they showing us by doubling down on home health and consumer wellness products?  Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

The Modern CXO's View on Consumer Innovation Christine Albert, Chief Experience Officer at LCMC Health, shares how consumer-centered leadership brings brands to life, why marketers are in the sweet spot to translate consumer initiatives to business leaders, and how to connect the dots between brand, culture, and experience to create people-centered leadership.  All that, plus the Flava of the Week about Amazon's new Health Condition programs. How does their partnership with Omada Health help everyday people connect with chronic health benefits that they already have, and how can we get better at integrating digital health solutions into consumers' health journeys?  Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

In this episode, Jen sits down with Vynamic's Deal Activation & Partnership Enablement Service Leads, Senior Director Kevin Fletcher and Executive Sean Martin, to discuss recent newsworthy items coming out of the J.P. Morgan Healthcare Conference, including the major acquisitions and deals announced, particularly those focused on AI and digital innovation.Check out Vynamic's Deal Activation & Partnership Enablement Service page to learn more about how Vynamic helps clients manage critical, time-sensitive activities across the deal life cycle. Podcast Tags: healthcare, healthcare news, life sciences, pharmaceutical, JP Morgan, deal activation, partnerships, mergers, acquisitions, AI, digital innovation Source Links: Inizio Biotech key takeaways from JPM industry event Cigna sells Medicare business to Health Care Service for $3.3 bln Bristol Myers Squibb Strengthens Neuroscience Portfolio with Acquisition of Karuna Therapeutics J&J, Merck and Boston Scientific Go on $6.4 Billion Buying Spree Amazon rolls out digital health benefits program, taps Omada Health as launch partner What the Health Care Sector Was Selling at the J.P. Morgan Confab Jefferson Health says LVHN merger would double its insurance business within 2 years Panel – Jen Burke, Kevin Fletcher, Sean Martin Research & Production – Anna Briccetti, Jen Burke Recording & Editing – Mike Liberto, Rachel Skonecki For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

Wei-Li Shao, President of Omada Health, joins us to discuss Omada's big splash: being named Amazon's first partner for their new Health Condition programs for managing chronic conditions. Wei-Li shares how this partnership is keeping the human element of healthcare front and center, and how designing experiences outside of the doctor's office is leading to real behavior change at scale.  All that, plus the Flava of the Week about Best Buy Health's year in review. Which of their highlights slipped under the radar in 2023, and what are they showing us by doubling down on home health and consumer wellness products?  This show is produced by Shift Forward Health, the consumer advisory firm that partners with you to operationalize consumer-first health. (#304)See omnystudio.com/listener for privacy information.

Big news from a16z: Bio Eats World, our sibling show from a16z Bio+Health, is now Raising Health!We're excited to share Raising Health's first episode here where Sean Duffy, cofounder and CEO of Omada Health, joins Vijay Pande, founding general partner of Bio + Health.Sean and Vijay discuss the building and growth of Omada, from the early days to now. As the cofounder of one of the original digital health companies, Sean has unique insight into the growth of both the digital health field and the changing venture capital environment. They also talk about the future of AI, how Omada is leveraging AI, and the challenges that might arise with using a technology in a caregiving environment.You can listen to more episodes of Raising Health here: https://link.chtbl.com/IqBoJ2By?sid=a16z11824

Christine Albert, Chief Experience Officer at LCMC Health, shares how consumer-centered leadership brings brands to life, why marketers are in the sweet spot to translate consumer initiatives to business leaders, and how to connect the dots between brand, culture, and experience to create people-centered leadership.  All that, plus the Flava of the Week about Amazon's new Health Condition programs. How does their partnership with Omada Health help everyday people connect with chronic health benefits that they already have, and how can we get better at integrating digital health solutions into consumers' health journeys?  This show is produced by Shift Forward Health, the consumer advisory firm that partners with you to operationalize consumer-first health. (#303) See omnystudio.com/listener for privacy information.

Host Dr. Nick van Terheyden aka Dr. Nick, discusses Chasing the Silver Bullet with Carolyn Jasik, MD, CMO for Omada Health. Their discussion includes exploring the potential of GLP-1 agonists in obesity treatment, understanding limitations of these medications, including side effects, high costs, the necessity for sustained lifestyle changes to maintain weight loss, combating obesity with root drivers (nutrition, food security, community design, and physical movement), expanding drug pipeline and the need to tackle systemic barriers like prohibitive costs and limited access, embrace a comprehensive approach to obesity care, combining pharmacological options with policy changes for a more effective and sustainable impact on individual and societal well-being. To stream our Station live 24/7 visit www.HealthcareNOWRadio.com or ask your Smart Device to “….Play Healthcare NOW Radio”. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

U.S. stocks rose Monday. Plus, ULA successfully launches Vulcan rocket, Amazon partners with Omada Health, and Audacy files for bankruptcy protection.

Bio Eats World is now Raising Health!On this first episode of Raising Health, Sean Duffy, cofounder and CEO of Omada Health, joins Vijay Pande, founding partner of Bio + Health.Sean and Vijay discuss the building and growth of Omada, from the early days to now. As the cofounder of one of the original digital health companies, Sean has unique insight into the growth of both the digital health field and the changing venture capital environment.  They also talk about the future of AI, how Omada is leveraging AI, and the challenges that might arise with using a technology in a caregiving environment.

Wondering if remote or flex culture is going away? It's not, sorry! So might as well embrace it. In today's episode, Cynthia Abbott Kerr, MS and I talk more about how companies can enhance remote culture, how to stay competitive with compensation/rewards and how to be a better leader.  Cynthia Abbott Kerr is the CEO of Wellpay.ai. Cynthia co-founded Wellpay.ai in 2022 alongside her husband and business partner, Dr Richard Kerr. With Cynthia's vision, Wellpay.ai has built groundbreaking technology that promises to disrupt the compensation space. Cynthia brings over 15 years of experience driving innovation in the Compensation sector. She previously led Total Rewards for Omada Health, where she developed best in class Compensation and Rewards programs. Under Cynthia's leadership Omada implemented Workday HCM in 6 months! Prior to her startup career, Cynthia held key Compensation roles at Tenet Healthcare and Ultra Clean Technology. Cynthia is considered a rising star in the Silicon Valley tech ecosystem. She has been awarded the top voice in Salary Negation, by LinkedIn. Cynthia holds a B.A. in Economics from Virginia Tech and a Masters in Human Resource Management from Mercy University. Outside of her CEO role, she volunteers with Second Harvest food bank and the SPCA. Cynthia is passionate about Compensation education and ensuring everyone is well paid. You can find more on Wellpay HERE and Cynthia HERESupport the show HERE for exclusive access and bonus episodes! This is an episode that you do not want to miss!Also, if you haven't already done so already, follow the podcast on LinkedIn HERE.  I'm adding a bunch of bonus episodes to the feed and, if you're not following, there's a good chance you'll miss out.Join 1K+ women receiving  my weekly newsletter where I help YOU level up your recruiting skills, share market insights also with all the tips on how to recruit your next Rockstar HERESupport the show

Join us this week as we welcome Wei-Li Shao, the President of Omada Health.What you'll get from this episode:Introduction to Wei-Li Shao, President of Omada HealthShao's journey from pharmaceuticals to digital health leadershipOmada Health's vision and impact in chronic careThe global reach of digital health: insights from Shao's experienceFuture of healthcare technology and innovations to watch“AmplifyMD immediately connects medical facilities to a large network of physicians in all of the most essential specialties, including Neurology, Cardiology, Infectious Disease, Pulmonology and Heme/Onc.” Their mission is access, by becoming the definitive specialty care platform that connects every medical facility to the specialty care they need to improve patient outcomes. - https://amplifymd.com/Learn more about Dr Wang and his initiativeshttps://www.linkedin.com/in/wshao/ https://www.omadahealth.com/Follow The Seamless Connection: https://www.linkedin.com/company/the-seamless-connection

In episode sixty-eight, we speak with Sean Duffy the Co-Founder & CEO at Omada Health about virtual care, how they achieve the right level of outcomes and value by being proactive and persistent, and building drones!

Host David Harlow speaks with Sean Duffy, co-founder and CEO of Omada Health. They talk about his company's journey as a digital health pioneer, finding footholds within the existing health care system — through research, certifications, payment innovations, and synchronous and asynchronous remote care — and working to update and expand the dominant care model. To stream our Station live 24/7 visit www.HealthcareNOWRadio.com or ask your Smart Device to “….Play Healthcare NOW Radio”. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

Jacob and Nikhil sit down with Sean Duffy, the CEO of health tech unicorn Omada Health, to discuss how Omada is using Large Language Models and incorporating GLP-1s into its care. They also hit on how Omada has thought and evolved its employer pricing. 0:00 intro0:43 starting Omada Health5:14 how Omada differs from Sean's original vision8:58 evolving employer pricing16:31 how the care model has changed over time 19:25 GLP-1s27:14 how Omada has incorporated AI36:12 Livongo-Teladoc merger40:20 coining the term “digital therapeutics”43:14 over-hyped/under-hyped44:47 policy changes that could improve healthcare

Chronic diseases are the result of a combination of genetic, physiological, environmental and behavioral factors. They require long-term management and often behavioral changes. Achieving long-lasting effects can be extremely difficult, and digital health solutions have since the beginning been seen as an important factor in assuring success, by providing patients with continuous monitoring and feedback. Omada Health is a US digital behavioral medicine company that uses digital tools and personalized support to help individuals living with prediabetes, diabetes, hypertension, and musculoskeletal issues. It's been present on the market for over a decade, so in this discussion, you will hear the CEO Sean Duffy talk about what exactly does Omada do differently compared to traditional chronic care management providers, we discussed approaches to providing sustainable long-term chronic care management, and touched the topic of the sharp rise in popularity of GLP-1 inhibitors, we've seen in the last year. GLP-1 inhibitors are drugs that are used for treating diabetes but have become a popular weight loss tool for many people.  SPONSOR https://magicmind.com/digitalhealth For discount, use the code: digitalhealth20

Today's episode is with Sean Duffy, cofounder and CEO of Omada Health. He is joined by a16z Bio + Health general partner Julie Yoo and investment partner Jay Rughani. Together, they talk about Sean's three rules of partnerships, how Omada plans for large-scale implementation, and how Sean thinks about structuring the economic model of the partnership.This episode was recorded as part of our research into our forthcoming Go to Market Playbook, focused on channel partnerships. Stay tuned for that, which we'll be releasing in the coming days at a16z.com/digital-health-builders.

Like it or not, data brokers have probably monetized your health data. But how do they get it in the first place? And what measures can you take to safeguard your health data? In this enlightening episode, I talk to data privacy expert Lucia Savage to find out. Lucia was formerly Chief Privacy Officer at the US Department of Health and Human Services, and is currently Chief Privacy and Regulatory Officer at Omada Health. Follow guest Lucia Savage on Twitter.Follow host Halle Tecco on Twitter.Visit the Heart of Healthcare website for episode recaps and more!See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In this episode we are learning about UNITY Screen non-invasive prenatal testing (NIPT) for recessive conditions. Joining our host Kira Dineen are two experts from BillionToOne, the CEO Oguzhan Atay and the Senior Director of Medical Affairs, Jen Hoskovec. Stay tuned for our part two about their new fetal antigen NIPT! Oguzhan Atay, PhD, BillionToOne co-founder, has led the company since its inception and raised more than $200M in funding including from venture capital funds and investors who previously invested in tech companies such as SpaceX, Box, Spotify, Palantir, Braintree, and biotech companies such as Counsyl, WebMD, and Omada Health! Oguzhan received his PhD from Stanford University, where his work was published on the Cover of Cell Systems. He graduated summa cum laude and Phi Beta Kappa from Princeton University with a bachelor's in molecular biology and minors in physics, computer science, and applied mathematics.Jennifer Hoskovec, MS, CGC, joined BillionToOne as the Senior Director of Medical Affairs in July 2020. As a certified genetic counselor with over 17 years of clinical experience, Jen is committed to ensuring patients and providers are supported and educated about the options and utility of prenatal testing. Jen joined BillionToOne after 17 years as a prenatal genetic counselor at UTHealth where she led a team of genetic counselors providing patient care in MFM clinics across the city of Houston. Jen has extensive volunteer and leadership experience within national societies such as American College of Obstetrics and Gynecology and National Society of Genetic Counselors. She served as president of NSGC in 2014. Jen earned her MS in genetic counseling from the University of Texas Health Science Center in Houston and her Bachelor of Science in Biology with a minor in Chemistry from Truman State University.On this episode we discuss:Noninvasive prenatal testing (NIPT)What is UNITY Screen and why the name UNITY?Recessive conditions included in UNITY ScreenInformation included in a UNITY NIPT reportTest specificity and sensitivity differences between ethnicitiesHow typical carrier screening flows work differently with UNITYWhy it is helpful to have information regarding the chance a pregnancy is affected by a recessive conditionBillionToOne's plans to include more recessive conditions in UNITY ScreenTo stay up to date with the latest developments at BillionToOne, follow them on Twitter, facebook and LinkedIn. You can also connect with our guest, Jen Hoskovec on Twitter. Stay tuned for the next new episode of DNA Today on February 24th, 2023 where we continue this NIPT discussion with Jen Hoskovec focusing on screening for antigens. New episodes are released every Friday. In the meantime, you can binge over 220 other episodes on Apple Podcasts, Spotify, streaming on the website, or any other podcast player by searching, “DNA Today”. Episodes since 2021 are also recorded with video which you can watch on our YouTube channel. DNA Today is hosted and produced by Kira Dineen. Our social media lead is Corinne Merlino. Our video lead is Amanda Andreoli. Our outreach Intern is Sanya Tinaikar. Our Social Media Intern is Kajal Patel. And our Graphic Designer Ashlyn Enokian.See what else we are up to on Twitter, Instagram, Facebook, YouTube and our website, DNAToday.com. Questions/inquiries can be sent to info@DNAtoday.com. If you've been listening to DNA Today for a while, you probably know I am also a full time prenatal genetic counselor. Between that job, this podcast, and being a producer/host of other podcasts, I am pretty busy! To keep my energy up and stay productive I drink a decent amount of coffee. The new coffee I'm drinking is from Four Sigmatic. I'm really picky about my coffee, it's got to be bold, not watery. And I've been really happy with Four Sigmatic. Here's the difference from other coffees, it includes mushrooms, which I know sounds bizarre. I will admit I was hesitant, but you get health benefits and don't taste it. I like the immune system boost, as I often get sick in the winter months. So we teamed up with Four SIgmatic to get you 30% off using promo code “DNATODAY” redeem it at FourSigmatic.com, again that's FourSigmatic.com using code “DNATODAY” for 30% off! And let me know if you like it too! (Sponsored)Which drug do you prescribe for your HER2+ cancer patients? For the first time in history TruGene Diagnostics (formerly Blueprint Diagnostics) informs you which of the 3 leading cancer drugs your patient is sensitive to and resistant to. TruGene Diagnostics knows the functional effect of EVERY mutation in the TK region of HER2 Gene. And knows the functional effect with and without the 3 most common drugs present. Thus allowing you to match the best drug to the patient. Unlock the best drug for your patients with HER2+ cancer using TruGene Diagnostics. Check it out at TruGeneDiagnostics.com. Stay tuned for our interview with them! (Sponsored)

Jared Erondu is a design & product leader, investor, and advisor. He's currently the GM of Performance and VP of Design at Lattice. Before Lattice, Jared led design at Teespring and was an early designer at both Obvious Corp and Omada Health. He's also founded two companies and consulted for others like Y Combinator, MIT Media Lab, Google, Front, and Greylock Partners. In his spare time, he likes to spin up projects that help further knowledge sharing in the design community, most notably Playbook and High Resolution. INTERVIEW VIDEO:https://youtu.be/MfrwNIJ19-ICONNECT WITH JARED ERONDULinkedIn - https://www.linkedin.com/in/erondu/Twitter - https://twitter.com/eronduCONNECT WITH MELinkedIn - https://www.linkedin.com/in/jayneil Twitter - https://twitter.com/jayneildalal 

Sean Duffy has already raised hundreds of millions of dollars for his enterprise health company that is blending technology and medicine together. The venture, Omada Health, attracted funding from top-tier investors like Wellington Management, Empede Capital, aMoon Fund, and Civilization Ventures.